nodes	percent_of_prediction	percent_of_DWPC	metapath
Dapagliflozin—UGT2B7—Pitavastatin—coronary artery disease	0.0559	0.0885	CbGbCtD
Dapagliflozin—UGT2B7—Ezetimibe—coronary artery disease	0.0412	0.0653	CbGbCtD
Dapagliflozin—UGT2B7—Simvastatin—coronary artery disease	0.0383	0.0607	CbGbCtD
Dapagliflozin—UGT2B7—Lovastatin—coronary artery disease	0.0375	0.0594	CbGbCtD
Dapagliflozin—UGT2B7—Atorvastatin—coronary artery disease	0.0341	0.0541	CbGbCtD
Dapagliflozin—UGT2B7—Losartan—coronary artery disease	0.0312	0.0495	CbGbCtD
Dapagliflozin—ABCB1—Ticagrelor—coronary artery disease	0.0177	0.0281	CbGbCtD
Dapagliflozin—CYP2C9—Fenofibrate—coronary artery disease	0.0163	0.0258	CbGbCtD
Dapagliflozin—CYP1A2—Gemfibrozil—coronary artery disease	0.0145	0.0229	CbGbCtD
Dapagliflozin—CYP2C9—Gemfibrozil—coronary artery disease	0.013	0.0206	CbGbCtD
Dapagliflozin—CYP1A2—Clopidogrel—coronary artery disease	0.0125	0.0199	CbGbCtD
Dapagliflozin—UGT2B4—pericardium—coronary artery disease	0.0121	0.245	CbGeAlD
Dapagliflozin—CYP2C9—Clopidogrel—coronary artery disease	0.0113	0.0179	CbGbCtD
Dapagliflozin—ABCB1—Clopidogrel—coronary artery disease	0.011	0.0174	CbGbCtD
Dapagliflozin—ABCB1—Perindopril—coronary artery disease	0.011	0.0174	CbGbCtD
Dapagliflozin—CYP3A4—Ticagrelor—coronary artery disease	0.0106	0.0168	CbGbCtD
Dapagliflozin—CYP2C9—Pitavastatin—coronary artery disease	0.00987	0.0156	CbGbCtD
Dapagliflozin—CYP2C9—Valsartan—coronary artery disease	0.0096	0.0152	CbGbCtD
Dapagliflozin—ABCB1—Telmisartan—coronary artery disease	0.00958	0.0152	CbGbCtD
Dapagliflozin—ABCB1—Pitavastatin—coronary artery disease	0.00958	0.0152	CbGbCtD
Dapagliflozin—CYP3A4—Fenofibrate—coronary artery disease	0.00947	0.015	CbGbCtD
Dapagliflozin—ABCB1—Enalapril—coronary artery disease	0.00908	0.0144	CbGbCtD
Dapagliflozin—ABCB1—Lisinopril—coronary artery disease	0.00908	0.0144	CbGbCtD
Dapagliflozin—CYP2D6—Niacin—coronary artery disease	0.00783	0.0124	CbGbCtD
Dapagliflozin—ABCB1—Timolol—coronary artery disease	0.00772	0.0122	CbGbCtD
Dapagliflozin—CYP3A4—Gemfibrozil—coronary artery disease	0.00757	0.012	CbGbCtD
Dapagliflozin—CYP2C9—Rosuvastatin—coronary artery disease	0.00728	0.0115	CbGbCtD
Dapagliflozin—CYP2D6—Timolol—coronary artery disease	0.00728	0.0115	CbGbCtD
Dapagliflozin—CYP2C9—Acetylsalicylic acid—coronary artery disease	0.00709	0.0112	CbGbCtD
Dapagliflozin—ABCB1—Ezetimibe—coronary artery disease	0.00706	0.0112	CbGbCtD
Dapagliflozin—ABCB1—Acetylsalicylic acid—coronary artery disease	0.00688	0.0109	CbGbCtD
Dapagliflozin—ABCB1—Captopril—coronary artery disease	0.0068	0.0108	CbGbCtD
Dapagliflozin—CYP2C9—Simvastatin—coronary artery disease	0.00677	0.0107	CbGbCtD
Dapagliflozin—CYP2C9—cardial valve—coronary artery disease	0.00669	0.135	CbGeAlD
Dapagliflozin—CYP2C9—Lovastatin—coronary artery disease	0.00662	0.0105	CbGbCtD
Dapagliflozin—CYP2C9—Pravastatin—coronary artery disease	0.00662	0.0105	CbGbCtD
Dapagliflozin—CYP3A4—Clopidogrel—coronary artery disease	0.00657	0.0104	CbGbCtD
Dapagliflozin—ABCB1—Simvastatin—coronary artery disease	0.00657	0.0104	CbGbCtD
Dapagliflozin—ABCB1—Lovastatin—coronary artery disease	0.00642	0.0102	CbGbCtD
Dapagliflozin—ABCB1—Pravastatin—coronary artery disease	0.00642	0.0102	CbGbCtD
Dapagliflozin—CYP2D6—Captopril—coronary artery disease	0.00641	0.0101	CbGbCtD
Dapagliflozin—CYP2D6—Simvastatin—coronary artery disease	0.00619	0.0098	CbGbCtD
Dapagliflozin—CYP1A2—Losartan—coronary artery disease	0.00612	0.0097	CbGbCtD
Dapagliflozin—CYP3A4—Eplerenone—coronary artery disease	0.0061	0.00967	CbGbCtD
Dapagliflozin—CYP2D6—Pravastatin—coronary artery disease	0.00605	0.00959	CbGbCtD
Dapagliflozin—CYP2D6—Lovastatin—coronary artery disease	0.00605	0.00959	CbGbCtD
Dapagliflozin—CYP2C9—Atorvastatin—coronary artery disease	0.00603	0.00955	CbGbCtD
Dapagliflozin—ABCB1—Atorvastatin—coronary artery disease	0.00585	0.00927	CbGbCtD
Dapagliflozin—CYP2C9—Losartan—coronary artery disease	0.00551	0.00874	CbGbCtD
Dapagliflozin—CYP2D6—Atorvastatin—coronary artery disease	0.00551	0.00873	CbGbCtD
Dapagliflozin—CYP3A4—Enalapril—coronary artery disease	0.00544	0.00862	CbGbCtD
Dapagliflozin—ABCB1—Losartan—coronary artery disease	0.00535	0.00848	CbGbCtD
Dapagliflozin—CYP3A4—Rosuvastatin—coronary artery disease	0.00423	0.0067	CbGbCtD
Dapagliflozin—CYP3A4—Ezetimibe—coronary artery disease	0.00423	0.0067	CbGbCtD
Dapagliflozin—CYP3A4—Simvastatin—coronary artery disease	0.00393	0.00623	CbGbCtD
Dapagliflozin—CYP3A4—Lovastatin—coronary artery disease	0.00385	0.0061	CbGbCtD
Dapagliflozin—CYP3A4—Pravastatin—coronary artery disease	0.00385	0.0061	CbGbCtD
Dapagliflozin—CYP3A4—Atorvastatin—coronary artery disease	0.00351	0.00555	CbGbCtD
Dapagliflozin—CYP3A4—Losartan—coronary artery disease	0.00321	0.00508	CbGbCtD
Dapagliflozin—SLC5A1—cardiac ventricle—coronary artery disease	0.0031	0.0626	CbGeAlD
Dapagliflozin—SLC5A1—myocardium—coronary artery disease	0.00292	0.0589	CbGeAlD
Dapagliflozin—UGT2B4—cardiac ventricle—coronary artery disease	0.00286	0.0577	CbGeAlD
Dapagliflozin—UGT2B4—myocardium—coronary artery disease	0.00269	0.0542	CbGeAlD
Dapagliflozin—SLC5A11—blood—coronary artery disease	0.0024	0.0485	CbGeAlD
Dapagliflozin—SLC5A1—heart—coronary artery disease	0.00204	0.0411	CbGeAlD
Dapagliflozin—SLC5A2—blood—coronary artery disease	0.00201	0.0405	CbGeAlD
Dapagliflozin—SLC5A1—cardiovascular system—coronary artery disease	0.00192	0.0388	CbGeAlD
Dapagliflozin—UGT2B4—heart—coronary artery disease	0.00188	0.0379	CbGeAlD
Dapagliflozin—UGT2B4—cardiovascular system—coronary artery disease	0.00177	0.0357	CbGeAlD
Dapagliflozin—SLC5A1—cardiac atrium—coronary artery disease	0.00174	0.0351	CbGeAlD
Dapagliflozin—UGT2B4—cardiac atrium—coronary artery disease	0.00161	0.0324	CbGeAlD
Dapagliflozin—Canagliflozin—ALB—coronary artery disease	0.000604	1	CrCbGaD
Dapagliflozin—CYP1A1—cardiac ventricle—coronary artery disease	0.000585	0.0118	CbGeAlD
Dapagliflozin—CYP1A1—heart—coronary artery disease	0.000384	0.00774	CbGeAlD
Dapagliflozin—CYP2C9—heart—coronary artery disease	0.000369	0.00745	CbGeAlD
Dapagliflozin—CYP2C9—cardiovascular system—coronary artery disease	0.000349	0.00703	CbGeAlD
Dapagliflozin—CYP1A1—cardiac atrium—coronary artery disease	0.000328	0.00662	CbGeAlD
Dapagliflozin—CYP1A2—blood—coronary artery disease	0.00029	0.00586	CbGeAlD
Dapagliflozin—CYP1A1—blood—coronary artery disease	0.000286	0.00578	CbGeAlD
Dapagliflozin—CYP2C9—blood—coronary artery disease	0.000276	0.00556	CbGeAlD
Dapagliflozin—CYP3A4—blood—coronary artery disease	0.00021	0.00424	CbGeAlD
Dapagliflozin—CYP2D6—blood—coronary artery disease	0.000207	0.00417	CbGeAlD
Dapagliflozin—ABCB1—heart—coronary artery disease	0.000199	0.00402	CbGeAlD
Dapagliflozin—ABCB1—cardiovascular system—coronary artery disease	0.000188	0.00379	CbGeAlD
Dapagliflozin—ABCB1—blood—coronary artery disease	0.000149	0.003	CbGeAlD
Dapagliflozin—Hypertension—Perindopril—coronary artery disease	0.000146	0.000869	CcSEcCtD
Dapagliflozin—Hypotension—Niacin—coronary artery disease	0.000145	0.000865	CcSEcCtD
Dapagliflozin—Infection—Telmisartan—coronary artery disease	0.000145	0.000864	CcSEcCtD
Dapagliflozin—Constipation—Simvastatin—coronary artery disease	0.000145	0.000862	CcSEcCtD
Dapagliflozin—Angioedema—Losartan—coronary artery disease	0.000145	0.000862	CcSEcCtD
Dapagliflozin—Urticaria—Clopidogrel—coronary artery disease	0.000145	0.000862	CcSEcCtD
Dapagliflozin—Skin disorder—Trandolapril—coronary artery disease	0.000145	0.00086	CcSEcCtD
Dapagliflozin—Nausea—Gemfibrozil—coronary artery disease	0.000144	0.000859	CcSEcCtD
Dapagliflozin—Body temperature increased—Clopidogrel—coronary artery disease	0.000144	0.000858	CcSEcCtD
Dapagliflozin—Urticaria—Lovastatin—coronary artery disease	0.000144	0.000857	CcSEcCtD
Dapagliflozin—Hyperhidrosis—Trandolapril—coronary artery disease	0.000144	0.000856	CcSEcCtD
Dapagliflozin—Hyperhidrosis—Enalapril—coronary artery disease	0.000143	0.000852	CcSEcCtD
Dapagliflozin—Body temperature increased—Lovastatin—coronary artery disease	0.000143	0.000852	CcSEcCtD
Dapagliflozin—Unspecified disorder of skin and subcutaneous tissue—Perindopril—coronary artery disease	0.000143	0.000851	CcSEcCtD
Dapagliflozin—Discomfort—Perindopril—coronary artery disease	0.000142	0.000846	CcSEcCtD
Dapagliflozin—Anaphylactic shock—Captopril—coronary artery disease	0.000142	0.000846	CcSEcCtD
Dapagliflozin—Skin disorder—Telmisartan—coronary artery disease	0.000142	0.000845	CcSEcCtD
Dapagliflozin—Dizziness—Rosuvastatin—coronary artery disease	0.000141	0.000841	CcSEcCtD
Dapagliflozin—Hyperhidrosis—Telmisartan—coronary artery disease	0.000141	0.000841	CcSEcCtD
Dapagliflozin—Urticaria—Ezetimibe—coronary artery disease	0.000141	0.00084	CcSEcCtD
Dapagliflozin—Nausea—Ticagrelor—coronary artery disease	0.000141	0.00084	CcSEcCtD
Dapagliflozin—Body temperature increased—Ezetimibe—coronary artery disease	0.000141	0.000836	CcSEcCtD
Dapagliflozin—Urinary tract disorder—Lisinopril—coronary artery disease	0.00014	0.000833	CcSEcCtD
Dapagliflozin—Hypotension—Trandolapril—coronary artery disease	0.000139	0.000827	CcSEcCtD
Dapagliflozin—Unspecified disorder of skin and subcutaneous tissue—Furosemide—coronary artery disease	0.000139	0.000827	CcSEcCtD
Dapagliflozin—Urethral disorder—Lisinopril—coronary artery disease	0.000139	0.000826	CcSEcCtD
Dapagliflozin—Hypotension—Enalapril—coronary artery disease	0.000139	0.000824	CcSEcCtD
Dapagliflozin—Gastrointestinal disorder—Valsartan—coronary artery disease	0.000138	0.000822	CcSEcCtD
Dapagliflozin—Anaphylactic shock—Perindopril—coronary artery disease	0.000138	0.000821	CcSEcCtD
Dapagliflozin—Oedema—Perindopril—coronary artery disease	0.000138	0.000821	CcSEcCtD
Dapagliflozin—Gastrointestinal disorder—Olmesartan—coronary artery disease	0.000138	0.000818	CcSEcCtD
Dapagliflozin—Body temperature increased—Eplerenone—coronary artery disease	0.000138	0.000818	CcSEcCtD
Dapagliflozin—Dizziness—Acetylsalicylic acid—coronary artery disease	0.000137	0.000817	CcSEcCtD
Dapagliflozin—Constipation—Valsartan—coronary artery disease	0.000137	0.000814	CcSEcCtD
Dapagliflozin—Hypersensitivity—Fenofibrate—coronary artery disease	0.000137	0.000814	CcSEcCtD
Dapagliflozin—Hypotension—Telmisartan—coronary artery disease	0.000137	0.000813	CcSEcCtD
Dapagliflozin—Constipation—Olmesartan—coronary artery disease	0.000136	0.000811	CcSEcCtD
Dapagliflozin—Malnutrition—Ramipril—coronary artery disease	0.000136	0.000809	CcSEcCtD
Dapagliflozin—Rash—Rosuvastatin—coronary artery disease	0.000135	0.000802	CcSEcCtD
Dapagliflozin—Dermatitis—Rosuvastatin—coronary artery disease	0.000135	0.000801	CcSEcCtD
Dapagliflozin—Urticaria—Simvastatin—coronary artery disease	0.000135	0.000801	CcSEcCtD
Dapagliflozin—Hypersensitivity—Clopidogrel—coronary artery disease	0.000134	0.0008	CcSEcCtD
Dapagliflozin—Gastrointestinal disorder—Niacin—coronary artery disease	0.000134	0.000799	CcSEcCtD
Dapagliflozin—Anaphylactic shock—Furosemide—coronary artery disease	0.000134	0.000798	CcSEcCtD
Dapagliflozin—Skin disorder—Perindopril—coronary artery disease	0.000134	0.000798	CcSEcCtD
Dapagliflozin—Body temperature increased—Simvastatin—coronary artery disease	0.000134	0.000797	CcSEcCtD
Dapagliflozin—Headache—Rosuvastatin—coronary artery disease	0.000134	0.000797	CcSEcCtD
Dapagliflozin—Hypersensitivity—Lovastatin—coronary artery disease	0.000134	0.000794	CcSEcCtD
Dapagliflozin—Hyperhidrosis—Perindopril—coronary artery disease	0.000133	0.000794	CcSEcCtD
Dapagliflozin—Discomfort—Losartan—coronary artery disease	0.000133	0.000794	CcSEcCtD
Dapagliflozin—Malnutrition—Timolol—coronary artery disease	0.000133	0.000791	CcSEcCtD
Dapagliflozin—Hypotension—Captopril—coronary artery disease	0.000133	0.00079	CcSEcCtD
Dapagliflozin—Constipation—Pravastatin—coronary artery disease	0.000131	0.00078	CcSEcCtD
Dapagliflozin—Rash—Acetylsalicylic acid—coronary artery disease	0.000131	0.000779	CcSEcCtD
Dapagliflozin—Hypersensitivity—Ezetimibe—coronary artery disease	0.000131	0.000779	CcSEcCtD
Dapagliflozin—Dermatitis—Acetylsalicylic acid—coronary artery disease	0.000131	0.000779	CcSEcCtD
Dapagliflozin—Skin disorder—Furosemide—coronary artery disease	0.00013	0.000775	CcSEcCtD
Dapagliflozin—Hyperhidrosis—Furosemide—coronary artery disease	0.00013	0.000772	CcSEcCtD
Dapagliflozin—Anaphylactic shock—Losartan—coronary artery disease	0.000129	0.00077	CcSEcCtD
Dapagliflozin—Oedema—Losartan—coronary artery disease	0.000129	0.00077	CcSEcCtD
Dapagliflozin—Hypotension—Perindopril—coronary artery disease	0.000129	0.000767	CcSEcCtD
Dapagliflozin—Infection—Losartan—coronary artery disease	0.000129	0.000765	CcSEcCtD
Dapagliflozin—Gastrointestinal disorder—Trandolapril—coronary artery disease	0.000129	0.000764	CcSEcCtD
Dapagliflozin—Constipation—Trandolapril—coronary artery disease	0.000127	0.000757	CcSEcCtD
Dapagliflozin—Urticaria—Valsartan—coronary artery disease	0.000127	0.000757	CcSEcCtD
Dapagliflozin—Nausea—Rosuvastatin—coronary artery disease	0.000127	0.000756	CcSEcCtD
Dapagliflozin—Constipation—Enalapril—coronary artery disease	0.000127	0.000754	CcSEcCtD
Dapagliflozin—Urticaria—Olmesartan—coronary artery disease	0.000127	0.000753	CcSEcCtD
Dapagliflozin—Gastrointestinal disorder—Telmisartan—coronary artery disease	0.000126	0.000751	CcSEcCtD
Dapagliflozin—Body temperature increased—Olmesartan—coronary artery disease	0.000126	0.000749	CcSEcCtD
Dapagliflozin—Hypotension—Furosemide—coronary artery disease	0.000125	0.000746	CcSEcCtD
Dapagliflozin—Hyperhidrosis—Losartan—coronary artery disease	0.000125	0.000745	CcSEcCtD
Dapagliflozin—Constipation—Telmisartan—coronary artery disease	0.000125	0.000744	CcSEcCtD
Dapagliflozin—Hypersensitivity—Simvastatin—coronary artery disease	0.000125	0.000743	CcSEcCtD
Dapagliflozin—Angioedema—Ramipril—coronary artery disease	0.000124	0.000739	CcSEcCtD
Dapagliflozin—Urticaria—Niacin—coronary artery disease	0.000124	0.000736	CcSEcCtD
Dapagliflozin—Nausea—Acetylsalicylic acid—coronary artery disease	0.000123	0.000734	CcSEcCtD
Dapagliflozin—Malnutrition—Lisinopril—coronary artery disease	0.000123	0.000734	CcSEcCtD
Dapagliflozin—Body temperature increased—Niacin—coronary artery disease	0.000123	0.000732	CcSEcCtD
Dapagliflozin—Dizziness—Fenofibrate—coronary artery disease	0.000123	0.00073	CcSEcCtD
Dapagliflozin—Urticaria—Pravastatin—coronary artery disease	0.000122	0.000724	CcSEcCtD
Dapagliflozin—Constipation—Captopril—coronary artery disease	0.000122	0.000723	CcSEcCtD
Dapagliflozin—Angioedema—Timolol—coronary artery disease	0.000122	0.000723	CcSEcCtD
Dapagliflozin—Body temperature increased—Pravastatin—coronary artery disease	0.000121	0.000721	CcSEcCtD
Dapagliflozin—Hypotension—Losartan—coronary artery disease	0.000121	0.00072	CcSEcCtD
Dapagliflozin—Dizziness—Clopidogrel—coronary artery disease	0.000121	0.000718	CcSEcCtD
Dapagliflozin—Dizziness—Lovastatin—coronary artery disease	0.00012	0.000713	CcSEcCtD
Dapagliflozin—Back pain—Lisinopril—coronary artery disease	0.000119	0.00071	CcSEcCtD
Dapagliflozin—Gastrointestinal disorder—Perindopril—coronary artery disease	0.000119	0.000709	CcSEcCtD
Dapagliflozin—Urticaria—Trandolapril—coronary artery disease	0.000118	0.000703	CcSEcCtD
Dapagliflozin—Constipation—Perindopril—coronary artery disease	0.000118	0.000702	CcSEcCtD
Dapagliflozin—Hypersensitivity—Valsartan—coronary artery disease	0.000118	0.000702	CcSEcCtD
Dapagliflozin—Urticaria—Enalapril—coronary artery disease	0.000118	0.000701	CcSEcCtD
Dapagliflozin—Body temperature increased—Trandolapril—coronary artery disease	0.000118	0.0007	CcSEcCtD
Dapagliflozin—Dizziness—Ezetimibe—coronary artery disease	0.000118	0.000699	CcSEcCtD
Dapagliflozin—Body temperature increased—Enalapril—coronary artery disease	0.000117	0.000697	CcSEcCtD
Dapagliflozin—Rash—Fenofibrate—coronary artery disease	0.000117	0.000696	CcSEcCtD
Dapagliflozin—Dermatitis—Fenofibrate—coronary artery disease	0.000117	0.000696	CcSEcCtD
Dapagliflozin—Headache—Fenofibrate—coronary artery disease	0.000116	0.000692	CcSEcCtD
Dapagliflozin—Urticaria—Telmisartan—coronary artery disease	0.000116	0.000691	CcSEcCtD
Dapagliflozin—Gastrointestinal disorder—Furosemide—coronary artery disease	0.000116	0.000689	CcSEcCtD
Dapagliflozin—Body temperature increased—Telmisartan—coronary artery disease	0.000116	0.000688	CcSEcCtD
Dapagliflozin—Dizziness—Eplerenone—coronary artery disease	0.000115	0.000684	CcSEcCtD
Dapagliflozin—Rash—Clopidogrel—coronary artery disease	0.000115	0.000684	CcSEcCtD
Dapagliflozin—Unspecified disorder of skin and subcutaneous tissue—Ramipril—coronary artery disease	0.000115	0.000684	CcSEcCtD
Dapagliflozin—Dermatitis—Clopidogrel—coronary artery disease	0.000115	0.000684	CcSEcCtD
Dapagliflozin—Hypertension—Timolol—coronary artery disease	0.000115	0.000683	CcSEcCtD
Dapagliflozin—Constipation—Furosemide—coronary artery disease	0.000115	0.000683	CcSEcCtD
Dapagliflozin—Hypersensitivity—Niacin—coronary artery disease	0.000115	0.000682	CcSEcCtD
Dapagliflozin—Discomfort—Ramipril—coronary artery disease	0.000114	0.000681	CcSEcCtD
Dapagliflozin—Headache—Clopidogrel—coronary artery disease	0.000114	0.00068	CcSEcCtD
Dapagliflozin—Rash—Lovastatin—coronary artery disease	0.000114	0.00068	CcSEcCtD
Dapagliflozin—Dermatitis—Lovastatin—coronary artery disease	0.000114	0.000679	CcSEcCtD
Dapagliflozin—Headache—Lovastatin—coronary artery disease	0.000114	0.000675	CcSEcCtD
Dapagliflozin—Hypersensitivity—Pravastatin—coronary artery disease	0.000113	0.000672	CcSEcCtD
Dapagliflozin—Angioedema—Lisinopril—coronary artery disease	0.000113	0.000671	CcSEcCtD
Dapagliflozin—Unspecified disorder of skin and subcutaneous tissue—Timolol—coronary artery disease	0.000112	0.000669	CcSEcCtD
Dapagliflozin—Body temperature increased—Captopril—coronary artery disease	0.000112	0.000669	CcSEcCtD
Dapagliflozin—Dizziness—Simvastatin—coronary artery disease	0.000112	0.000667	CcSEcCtD
Dapagliflozin—Rash—Ezetimibe—coronary artery disease	0.000112	0.000667	CcSEcCtD
Dapagliflozin—Dermatitis—Ezetimibe—coronary artery disease	0.000112	0.000666	CcSEcCtD
Dapagliflozin—Discomfort—Timolol—coronary artery disease	0.000112	0.000665	CcSEcCtD
Dapagliflozin—Headache—Ezetimibe—coronary artery disease	0.000111	0.000662	CcSEcCtD
Dapagliflozin—Oedema—Ramipril—coronary artery disease	0.000111	0.00066	CcSEcCtD
Dapagliflozin—Anaphylactic shock—Ramipril—coronary artery disease	0.000111	0.00066	CcSEcCtD
Dapagliflozin—Constipation—Losartan—coronary artery disease	0.000111	0.000659	CcSEcCtD
Dapagliflozin—Nausea—Fenofibrate—coronary artery disease	0.00011	0.000656	CcSEcCtD
Dapagliflozin—Rash—Eplerenone—coronary artery disease	0.00011	0.000653	CcSEcCtD
Dapagliflozin—Urticaria—Perindopril—coronary artery disease	0.00011	0.000652	CcSEcCtD
Dapagliflozin—Hypersensitivity—Trandolapril—coronary artery disease	0.00011	0.000652	CcSEcCtD
Dapagliflozin—Dermatitis—Eplerenone—coronary artery disease	0.00011	0.000652	CcSEcCtD
Dapagliflozin—Hypersensitivity—Enalapril—coronary artery disease	0.000109	0.00065	CcSEcCtD
Dapagliflozin—Body temperature increased—Perindopril—coronary artery disease	0.000109	0.000649	CcSEcCtD
Dapagliflozin—Headache—Eplerenone—coronary artery disease	0.000109	0.000648	CcSEcCtD
Dapagliflozin—Anaphylactic shock—Timolol—coronary artery disease	0.000109	0.000646	CcSEcCtD
Dapagliflozin—Oedema—Timolol—coronary artery disease	0.000109	0.000646	CcSEcCtD
Dapagliflozin—Nausea—Clopidogrel—coronary artery disease	0.000108	0.000645	CcSEcCtD
Dapagliflozin—Skin disorder—Ramipril—coronary artery disease	0.000108	0.000642	CcSEcCtD
Dapagliflozin—Infection—Timolol—coronary artery disease	0.000108	0.000641	CcSEcCtD
Dapagliflozin—Hypersensitivity—Telmisartan—coronary artery disease	0.000108	0.000641	CcSEcCtD
Dapagliflozin—Nausea—Lovastatin—coronary artery disease	0.000108	0.00064	CcSEcCtD
Dapagliflozin—Hyperhidrosis—Ramipril—coronary artery disease	0.000107	0.000638	CcSEcCtD
Dapagliflozin—Rash—Simvastatin—coronary artery disease	0.000107	0.000636	CcSEcCtD
Dapagliflozin—Dermatitis—Simvastatin—coronary artery disease	0.000107	0.000635	CcSEcCtD
Dapagliflozin—Urticaria—Furosemide—coronary artery disease	0.000107	0.000634	CcSEcCtD
Dapagliflozin—Headache—Simvastatin—coronary artery disease	0.000106	0.000632	CcSEcCtD
Dapagliflozin—Body temperature increased—Furosemide—coronary artery disease	0.000106	0.000631	CcSEcCtD
Dapagliflozin—Dizziness—Valsartan—coronary artery disease	0.000106	0.00063	CcSEcCtD
Dapagliflozin—Nausea—Ezetimibe—coronary artery disease	0.000106	0.000628	CcSEcCtD
Dapagliflozin—Skin disorder—Timolol—coronary artery disease	0.000105	0.000627	CcSEcCtD
Dapagliflozin—Dizziness—Olmesartan—coronary artery disease	0.000105	0.000627	CcSEcCtD
Dapagliflozin—Hyperhidrosis—Timolol—coronary artery disease	0.000105	0.000624	CcSEcCtD
Dapagliflozin—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—coronary artery disease	0.000104	0.000621	CcSEcCtD
Dapagliflozin—Discomfort—Lisinopril—coronary artery disease	0.000104	0.000617	CcSEcCtD
Dapagliflozin—Hypotension—Ramipril—coronary artery disease	0.000104	0.000617	CcSEcCtD
Dapagliflozin—Nausea—Eplerenone—coronary artery disease	0.000103	0.000615	CcSEcCtD
Dapagliflozin—Dizziness—Niacin—coronary artery disease	0.000103	0.000612	CcSEcCtD
Dapagliflozin—Urticaria—Losartan—coronary artery disease	0.000103	0.000612	CcSEcCtD
Dapagliflozin—Body temperature increased—Losartan—coronary artery disease	0.000102	0.000609	CcSEcCtD
Dapagliflozin—Hypotension—Timolol—coronary artery disease	0.000101	0.000603	CcSEcCtD
Dapagliflozin—Dizziness—Pravastatin—coronary artery disease	0.000101	0.000603	CcSEcCtD
Dapagliflozin—Rash—Valsartan—coronary artery disease	0.000101	0.0006	CcSEcCtD
Dapagliflozin—Dermatitis—Valsartan—coronary artery disease	0.000101	0.0006	CcSEcCtD
Dapagliflozin—Nausea—Simvastatin—coronary artery disease	0.000101	0.000599	CcSEcCtD
Dapagliflozin—Oedema—Lisinopril—coronary artery disease	0.000101	0.000599	CcSEcCtD
Dapagliflozin—Anaphylactic shock—Lisinopril—coronary artery disease	0.000101	0.000599	CcSEcCtD
Dapagliflozin—Rash—Olmesartan—coronary artery disease	0.0001	0.000598	CcSEcCtD
Dapagliflozin—Dermatitis—Olmesartan—coronary artery disease	0.0001	0.000597	CcSEcCtD
Dapagliflozin—Headache—Valsartan—coronary artery disease	0.0001	0.000597	CcSEcCtD
Dapagliflozin—Infection—Lisinopril—coronary artery disease	0.0001	0.000595	CcSEcCtD
Dapagliflozin—Headache—Olmesartan—coronary artery disease	9.98e-05	0.000594	CcSEcCtD
Dapagliflozin—Hypersensitivity—Furosemide—coronary artery disease	9.89e-05	0.000588	CcSEcCtD
Dapagliflozin—Dizziness—Trandolapril—coronary artery disease	9.84e-05	0.000585	CcSEcCtD
Dapagliflozin—Rash—Niacin—coronary artery disease	9.82e-05	0.000584	CcSEcCtD
Dapagliflozin—Dermatitis—Niacin—coronary artery disease	9.81e-05	0.000583	CcSEcCtD
Dapagliflozin—Dizziness—Enalapril—coronary artery disease	9.8e-05	0.000583	CcSEcCtD
Dapagliflozin—Skin disorder—Lisinopril—coronary artery disease	9.78e-05	0.000582	CcSEcCtD
Dapagliflozin—Headache—Niacin—coronary artery disease	9.75e-05	0.00058	CcSEcCtD
Dapagliflozin—Hyperhidrosis—Lisinopril—coronary artery disease	9.74e-05	0.000579	CcSEcCtD
Dapagliflozin—Dizziness—Telmisartan—coronary artery disease	9.67e-05	0.000575	CcSEcCtD
Dapagliflozin—Rash—Pravastatin—coronary artery disease	9.66e-05	0.000575	CcSEcCtD
Dapagliflozin—Dermatitis—Pravastatin—coronary artery disease	9.66e-05	0.000574	CcSEcCtD
Dapagliflozin—Headache—Pravastatin—coronary artery disease	9.6e-05	0.000571	CcSEcCtD
Dapagliflozin—Gastrointestinal disorder—Ramipril—coronary artery disease	9.59e-05	0.00057	CcSEcCtD
Dapagliflozin—Hypersensitivity—Losartan—coronary artery disease	9.54e-05	0.000567	CcSEcCtD
Dapagliflozin—Nausea—Valsartan—coronary artery disease	9.51e-05	0.000566	CcSEcCtD
Dapagliflozin—Constipation—Ramipril—coronary artery disease	9.5e-05	0.000565	CcSEcCtD
Dapagliflozin—Nausea—Olmesartan—coronary artery disease	9.46e-05	0.000563	CcSEcCtD
Dapagliflozin—Hypotension—Lisinopril—coronary artery disease	9.41e-05	0.00056	CcSEcCtD
Dapagliflozin—Dizziness—Captopril—coronary artery disease	9.4e-05	0.000559	CcSEcCtD
Dapagliflozin—Rash—Trandolapril—coronary artery disease	9.39e-05	0.000558	CcSEcCtD
Dapagliflozin—Dermatitis—Trandolapril—coronary artery disease	9.38e-05	0.000558	CcSEcCtD
Dapagliflozin—Gastrointestinal disorder—Timolol—coronary artery disease	9.37e-05	0.000557	CcSEcCtD
Dapagliflozin—Rash—Enalapril—coronary artery disease	9.35e-05	0.000556	CcSEcCtD
Dapagliflozin—Dermatitis—Enalapril—coronary artery disease	9.34e-05	0.000556	CcSEcCtD
Dapagliflozin—Headache—Trandolapril—coronary artery disease	9.33e-05	0.000555	CcSEcCtD
Dapagliflozin—Headache—Enalapril—coronary artery disease	9.29e-05	0.000552	CcSEcCtD
Dapagliflozin—Nausea—Niacin—coronary artery disease	9.25e-05	0.00055	CcSEcCtD
Dapagliflozin—Rash—Telmisartan—coronary artery disease	9.22e-05	0.000548	CcSEcCtD
Dapagliflozin—Dermatitis—Telmisartan—coronary artery disease	9.21e-05	0.000548	CcSEcCtD
Dapagliflozin—Headache—Telmisartan—coronary artery disease	9.16e-05	0.000545	CcSEcCtD
Dapagliflozin—Dizziness—Perindopril—coronary artery disease	9.13e-05	0.000543	CcSEcCtD
Dapagliflozin—Nausea—Pravastatin—coronary artery disease	9.1e-05	0.000542	CcSEcCtD
Dapagliflozin—Rash—Captopril—coronary artery disease	8.97e-05	0.000533	CcSEcCtD
Dapagliflozin—Dermatitis—Captopril—coronary artery disease	8.96e-05	0.000533	CcSEcCtD
Dapagliflozin—Headache—Captopril—coronary artery disease	8.91e-05	0.00053	CcSEcCtD
Dapagliflozin—Dizziness—Furosemide—coronary artery disease	8.88e-05	0.000528	CcSEcCtD
Dapagliflozin—Nausea—Trandolapril—coronary artery disease	8.84e-05	0.000526	CcSEcCtD
Dapagliflozin—Urticaria—Ramipril—coronary artery disease	8.82e-05	0.000525	CcSEcCtD
Dapagliflozin—Nausea—Enalapril—coronary artery disease	8.81e-05	0.000524	CcSEcCtD
Dapagliflozin—Body temperature increased—Ramipril—coronary artery disease	8.78e-05	0.000522	CcSEcCtD
Dapagliflozin—Rash—Perindopril—coronary artery disease	8.7e-05	0.000518	CcSEcCtD
Dapagliflozin—Dermatitis—Perindopril—coronary artery disease	8.7e-05	0.000517	CcSEcCtD
Dapagliflozin—Gastrointestinal disorder—Lisinopril—coronary artery disease	8.69e-05	0.000517	CcSEcCtD
Dapagliflozin—Nausea—Telmisartan—coronary artery disease	8.69e-05	0.000517	CcSEcCtD
Dapagliflozin—Headache—Perindopril—coronary artery disease	8.65e-05	0.000514	CcSEcCtD
Dapagliflozin—Urticaria—Timolol—coronary artery disease	8.62e-05	0.000513	CcSEcCtD
Dapagliflozin—Constipation—Lisinopril—coronary artery disease	8.61e-05	0.000512	CcSEcCtD
Dapagliflozin—Body temperature increased—Timolol—coronary artery disease	8.58e-05	0.00051	CcSEcCtD
Dapagliflozin—Dizziness—Losartan—coronary artery disease	8.56e-05	0.000509	CcSEcCtD
Dapagliflozin—Rash—Furosemide—coronary artery disease	8.46e-05	0.000503	CcSEcCtD
Dapagliflozin—Dermatitis—Furosemide—coronary artery disease	8.45e-05	0.000503	CcSEcCtD
Dapagliflozin—Nausea—Captopril—coronary artery disease	8.45e-05	0.000502	CcSEcCtD
Dapagliflozin—Headache—Furosemide—coronary artery disease	8.41e-05	0.0005	CcSEcCtD
Dapagliflozin—Nausea—Perindopril—coronary artery disease	8.2e-05	0.000488	CcSEcCtD
Dapagliflozin—Hypersensitivity—Ramipril—coronary artery disease	8.18e-05	0.000487	CcSEcCtD
Dapagliflozin—Rash—Losartan—coronary artery disease	8.16e-05	0.000486	CcSEcCtD
Dapagliflozin—Dermatitis—Losartan—coronary artery disease	8.16e-05	0.000485	CcSEcCtD
Dapagliflozin—Headache—Losartan—coronary artery disease	8.11e-05	0.000483	CcSEcCtD
Dapagliflozin—Urticaria—Lisinopril—coronary artery disease	8e-05	0.000476	CcSEcCtD
Dapagliflozin—Hypersensitivity—Timolol—coronary artery disease	8e-05	0.000476	CcSEcCtD
Dapagliflozin—Nausea—Furosemide—coronary artery disease	7.97e-05	0.000474	CcSEcCtD
Dapagliflozin—Body temperature increased—Lisinopril—coronary artery disease	7.96e-05	0.000473	CcSEcCtD
Dapagliflozin—Nausea—Losartan—coronary artery disease	7.69e-05	0.000458	CcSEcCtD
Dapagliflozin—Hypersensitivity—Lisinopril—coronary artery disease	7.42e-05	0.000441	CcSEcCtD
Dapagliflozin—Dizziness—Ramipril—coronary artery disease	7.34e-05	0.000437	CcSEcCtD
Dapagliflozin—Dizziness—Timolol—coronary artery disease	7.18e-05	0.000427	CcSEcCtD
Dapagliflozin—Rash—Ramipril—coronary artery disease	7e-05	0.000416	CcSEcCtD
Dapagliflozin—Dermatitis—Ramipril—coronary artery disease	6.99e-05	0.000416	CcSEcCtD
Dapagliflozin—Headache—Ramipril—coronary artery disease	6.96e-05	0.000414	CcSEcCtD
Dapagliflozin—Rash—Timolol—coronary artery disease	6.84e-05	0.000407	CcSEcCtD
Dapagliflozin—Dermatitis—Timolol—coronary artery disease	6.84e-05	0.000407	CcSEcCtD
Dapagliflozin—Headache—Timolol—coronary artery disease	6.8e-05	0.000404	CcSEcCtD
Dapagliflozin—Dizziness—Lisinopril—coronary artery disease	6.66e-05	0.000396	CcSEcCtD
Dapagliflozin—Nausea—Ramipril—coronary artery disease	6.6e-05	0.000392	CcSEcCtD
Dapagliflozin—Nausea—Timolol—coronary artery disease	6.45e-05	0.000384	CcSEcCtD
Dapagliflozin—Rash—Lisinopril—coronary artery disease	6.35e-05	0.000378	CcSEcCtD
Dapagliflozin—Dermatitis—Lisinopril—coronary artery disease	6.34e-05	0.000377	CcSEcCtD
Dapagliflozin—Headache—Lisinopril—coronary artery disease	6.31e-05	0.000375	CcSEcCtD
Dapagliflozin—Nausea—Lisinopril—coronary artery disease	5.98e-05	0.000356	CcSEcCtD
Dapagliflozin—CYP2C9—Metabolism—GCLC—coronary artery disease	3.08e-06	2.05e-05	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—PSMB5—coronary artery disease	3.08e-06	2.05e-05	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—PSMA6—coronary artery disease	3.08e-06	2.05e-05	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—SDC1—coronary artery disease	3.07e-06	2.04e-05	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—SDC1—coronary artery disease	3.05e-06	2.03e-05	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—CYP11B2—coronary artery disease	3.02e-06	2.01e-05	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—TXNRD1—coronary artery disease	3.02e-06	2.01e-05	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—CTGF—coronary artery disease	3.01e-06	2e-05	CbGpPWpGaD
Dapagliflozin—CYP2A6—Metabolism—AGT—coronary artery disease	3e-06	1.99e-05	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—VCAN—coronary artery disease	2.99e-06	1.99e-05	CbGpPWpGaD
Dapagliflozin—UGT1A9—Metabolism—ALB—coronary artery disease	2.99e-06	1.99e-05	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—GOT2—coronary artery disease	2.98e-06	1.98e-05	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—HMGCR—coronary artery disease	2.98e-06	1.98e-05	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—SLC22A3—coronary artery disease	2.98e-06	1.98e-05	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—ALDOA—coronary artery disease	2.97e-06	1.97e-05	CbGpPWpGaD
Dapagliflozin—CYP2A6—Metabolism—APOE—coronary artery disease	2.94e-06	1.95e-05	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—ARNTL—coronary artery disease	2.93e-06	1.95e-05	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—HADH—coronary artery disease	2.93e-06	1.95e-05	CbGpPWpGaD
Dapagliflozin—ABCB1—Transmembrane transport of small molecules—ALB—coronary artery disease	2.92e-06	1.94e-05	CbGpPWpGaD
Dapagliflozin—CYP2A6—Metabolism—APOA1—coronary artery disease	2.91e-06	1.93e-05	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—PSMA6—coronary artery disease	2.9e-06	1.93e-05	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—PSMB5—coronary artery disease	2.9e-06	1.93e-05	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism—GSTP1—coronary artery disease	2.9e-06	1.93e-05	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—DCN—coronary artery disease	2.88e-06	1.91e-05	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—PSMB5—coronary artery disease	2.88e-06	1.91e-05	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—PSMA6—coronary artery disease	2.88e-06	1.91e-05	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism of lipids and lipoproteins—ALB—coronary artery disease	2.87e-06	1.91e-05	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism—PPARGC1A—coronary artery disease	2.87e-06	1.91e-05	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism—HMOX1—coronary artery disease	2.86e-06	1.9e-05	CbGpPWpGaD
Dapagliflozin—UGT1A9—Metabolism—NOS3—coronary artery disease	2.86e-06	1.9e-05	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—CTGF—coronary artery disease	2.84e-06	1.89e-05	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism—CAT—coronary artery disease	2.82e-06	1.87e-05	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—CTGF—coronary artery disease	2.81e-06	1.87e-05	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—GOT2—coronary artery disease	2.81e-06	1.87e-05	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—HMGCR—coronary artery disease	2.81e-06	1.87e-05	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—ALDH2—coronary artery disease	2.8e-06	1.86e-05	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—GOT2—coronary artery disease	2.79e-06	1.85e-05	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—HMGCR—coronary artery disease	2.79e-06	1.85e-05	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—APOA2—coronary artery disease	2.78e-06	1.85e-05	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—PLA2G2A—coronary artery disease	2.78e-06	1.85e-05	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—GPX2—coronary artery disease	2.78e-06	1.85e-05	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—ABCG5—coronary artery disease	2.75e-06	1.83e-05	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—SULT1A1—coronary artery disease	2.75e-06	1.83e-05	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—HK1—coronary artery disease	2.75e-06	1.83e-05	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—GPX4—coronary artery disease	2.75e-06	1.83e-05	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—PLCB1—coronary artery disease	2.74e-06	1.82e-05	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism—APOB—coronary artery disease	2.74e-06	1.82e-05	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—coronary artery disease	2.73e-06	1.82e-05	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—CYP2C19—coronary artery disease	2.73e-06	1.81e-05	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—LIPC—coronary artery disease	2.73e-06	1.81e-05	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—HBA1—coronary artery disease	2.73e-06	1.81e-05	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—PIK3C2A—coronary artery disease	2.73e-06	1.81e-05	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—HADHA—coronary artery disease	2.71e-06	1.8e-05	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—APOC3—coronary artery disease	2.71e-06	1.8e-05	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—LDLR—coronary artery disease	2.7e-06	1.79e-05	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism of lipids and lipoproteins—POMC—coronary artery disease	2.69e-06	1.79e-05	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—GSTA1—coronary artery disease	2.68e-06	1.78e-05	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—GSTT1—coronary artery disease	2.66e-06	1.77e-05	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—SLC9A1—coronary artery disease	2.66e-06	1.77e-05	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism—GSTM1—coronary artery disease	2.66e-06	1.77e-05	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—ABCA1—coronary artery disease	2.66e-06	1.77e-05	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—LPA—coronary artery disease	2.65e-06	1.76e-05	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—GCLC—coronary artery disease	2.63e-06	1.75e-05	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—CETP—coronary artery disease	2.63e-06	1.75e-05	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism—LPL—coronary artery disease	2.61e-06	1.74e-05	CbGpPWpGaD
Dapagliflozin—UGT1A9—Metabolism—PTGS2—coronary artery disease	2.61e-06	1.74e-05	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—SDC1—coronary artery disease	2.6e-06	1.73e-05	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—PLCB1—coronary artery disease	2.59e-06	1.72e-05	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—GGT1—coronary artery disease	2.58e-06	1.71e-05	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—GOT1—coronary artery disease	2.58e-06	1.71e-05	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—PLCB3—coronary artery disease	2.57e-06	1.71e-05	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—PLCB1—coronary artery disease	2.56e-06	1.7e-05	CbGpPWpGaD
Dapagliflozin—CYP2A6—Metabolism—PPARG—coronary artery disease	2.56e-06	1.7e-05	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism—GPX1—coronary artery disease	2.55e-06	1.69e-05	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—APOA5—coronary artery disease	2.54e-06	1.69e-05	CbGpPWpGaD
Dapagliflozin—CYP2A6—Metabolism—POMC—coronary artery disease	2.52e-06	1.68e-05	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—coronary artery disease	2.51e-06	1.67e-05	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—ABCA1—coronary artery disease	2.51e-06	1.67e-05	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—P4HB—coronary artery disease	2.49e-06	1.66e-05	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—ABCA1—coronary artery disease	2.48e-06	1.65e-05	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism—CD36—coronary artery disease	2.48e-06	1.65e-05	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—PSMB5—coronary artery disease	2.46e-06	1.64e-05	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—PSMA6—coronary artery disease	2.46e-06	1.64e-05	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism of lipids and lipoproteins—ALB—coronary artery disease	2.46e-06	1.63e-05	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism—PPP2CA—coronary artery disease	2.45e-06	1.63e-05	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—PLA2G1B—coronary artery disease	2.45e-06	1.63e-05	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—GOT1—coronary artery disease	2.43e-06	1.61e-05	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—GGT1—coronary artery disease	2.43e-06	1.61e-05	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—GGT1—coronary artery disease	2.41e-06	1.6e-05	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—GOT1—coronary artery disease	2.41e-06	1.6e-05	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—CTGF—coronary artery disease	2.4e-06	1.6e-05	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—HMGCR—coronary artery disease	2.38e-06	1.58e-05	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—GOT2—coronary artery disease	2.38e-06	1.58e-05	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism—MTHFR—coronary artery disease	2.35e-06	1.56e-05	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—GSTP1—coronary artery disease	2.31e-06	1.54e-05	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—VCAN—coronary artery disease	2.31e-06	1.53e-05	CbGpPWpGaD
Dapagliflozin—CYP2A6—Metabolism—ALB—coronary artery disease	2.3e-06	1.53e-05	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—PPARGC1A—coronary artery disease	2.29e-06	1.52e-05	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—ALDOA—coronary artery disease	2.29e-06	1.52e-05	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—HMOX1—coronary artery disease	2.28e-06	1.52e-05	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—CAT—coronary artery disease	2.25e-06	1.5e-05	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism—AGT—coronary artery disease	2.23e-06	1.49e-05	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—DCN—coronary artery disease	2.22e-06	1.48e-05	CbGpPWpGaD
Dapagliflozin—CYP2A6—Metabolism—NOS3—coronary artery disease	2.2e-06	1.46e-05	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—PLCB1—coronary artery disease	2.19e-06	1.46e-05	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism—APOE—coronary artery disease	2.19e-06	1.46e-05	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—APOB—coronary artery disease	2.19e-06	1.45e-05	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—GSTP1—coronary artery disease	2.18e-06	1.45e-05	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism—APOA1—coronary artery disease	2.16e-06	1.44e-05	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—ALDH2—coronary artery disease	2.16e-06	1.44e-05	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—GSTP1—coronary artery disease	2.16e-06	1.44e-05	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—PPARGC1A—coronary artery disease	2.16e-06	1.44e-05	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—HMOX1—coronary artery disease	2.15e-06	1.43e-05	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—coronary artery disease	2.15e-06	1.43e-05	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—PPARGC1A—coronary artery disease	2.14e-06	1.42e-05	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—HMOX1—coronary artery disease	2.13e-06	1.42e-05	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—GSTM1—coronary artery disease	2.13e-06	1.41e-05	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—ABCA1—coronary artery disease	2.12e-06	1.41e-05	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—CAT—coronary artery disease	2.12e-06	1.41e-05	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—LIPC—coronary artery disease	2.11e-06	1.4e-05	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—HBA1—coronary artery disease	2.11e-06	1.4e-05	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—PIK3C2A—coronary artery disease	2.11e-06	1.4e-05	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—CYP2C19—coronary artery disease	2.11e-06	1.4e-05	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—CAT—coronary artery disease	2.1e-06	1.4e-05	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—APOC3—coronary artery disease	2.09e-06	1.39e-05	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—LPL—coronary artery disease	2.09e-06	1.39e-05	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—LDLR—coronary artery disease	2.08e-06	1.38e-05	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	2.07e-06	1.38e-05	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—APOB—coronary artery disease	2.06e-06	1.37e-05	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—SLC9A1—coronary artery disease	2.06e-06	1.37e-05	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—GSTT1—coronary artery disease	2.06e-06	1.37e-05	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—GOT1—coronary artery disease	2.06e-06	1.37e-05	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—GGT1—coronary artery disease	2.06e-06	1.37e-05	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—APOB—coronary artery disease	2.04e-06	1.36e-05	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—GPX1—coronary artery disease	2.04e-06	1.35e-05	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—GCLC—coronary artery disease	2.03e-06	1.35e-05	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—CETP—coronary artery disease	2.03e-06	1.35e-05	CbGpPWpGaD
Dapagliflozin—CYP2A6—Metabolism—PTGS2—coronary artery disease	2.01e-06	1.34e-05	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—SDC1—coronary artery disease	2.01e-06	1.34e-05	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—GSTM1—coronary artery disease	2e-06	1.33e-05	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—GSTM1—coronary artery disease	1.99e-06	1.32e-05	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—CD36—coronary artery disease	1.98e-06	1.32e-05	CbGpPWpGaD
Dapagliflozin—UGT2B7—Metabolism—PIK3CA—coronary artery disease	1.98e-06	1.32e-05	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—LPL—coronary artery disease	1.97e-06	1.31e-05	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—PPP2CA—coronary artery disease	1.96e-06	1.3e-05	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—LPL—coronary artery disease	1.95e-06	1.3e-05	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—GPX1—coronary artery disease	1.92e-06	1.28e-05	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism—PPARG—coronary artery disease	1.91e-06	1.27e-05	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—GPX1—coronary artery disease	1.9e-06	1.26e-05	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—PSMB5—coronary artery disease	1.9e-06	1.26e-05	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—PSMA6—coronary artery disease	1.9e-06	1.26e-05	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism—POMC—coronary artery disease	1.88e-06	1.25e-05	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—MTHFR—coronary artery disease	1.88e-06	1.25e-05	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—CD36—coronary artery disease	1.87e-06	1.24e-05	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—CTGF—coronary artery disease	1.85e-06	1.23e-05	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—CD36—coronary artery disease	1.85e-06	1.23e-05	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—GSTP1—coronary artery disease	1.85e-06	1.23e-05	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—PPP2CA—coronary artery disease	1.84e-06	1.23e-05	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—HMGCR—coronary artery disease	1.84e-06	1.22e-05	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—GOT2—coronary artery disease	1.84e-06	1.22e-05	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—PPARGC1A—coronary artery disease	1.83e-06	1.22e-05	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—PPP2CA—coronary artery disease	1.83e-06	1.22e-05	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—HMOX1—coronary artery disease	1.82e-06	1.21e-05	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—CAT—coronary artery disease	1.8e-06	1.19e-05	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—AGT—coronary artery disease	1.79e-06	1.19e-05	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—MTHFR—coronary artery disease	1.77e-06	1.18e-05	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—MTHFR—coronary artery disease	1.76e-06	1.17e-05	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—APOE—coronary artery disease	1.75e-06	1.16e-05	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—APOB—coronary artery disease	1.74e-06	1.16e-05	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—APOA1—coronary artery disease	1.73e-06	1.15e-05	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism—ALB—coronary artery disease	1.72e-06	1.14e-05	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—GSTM1—coronary artery disease	1.7e-06	1.13e-05	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—PLCB1—coronary artery disease	1.69e-06	1.12e-05	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—AGT—coronary artery disease	1.68e-06	1.12e-05	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—AGT—coronary artery disease	1.67e-06	1.11e-05	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—LPL—coronary artery disease	1.67e-06	1.11e-05	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—APOE—coronary artery disease	1.65e-06	1.1e-05	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism—NOS3—coronary artery disease	1.64e-06	1.09e-05	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—ABCA1—coronary artery disease	1.64e-06	1.09e-05	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—APOE—coronary artery disease	1.63e-06	1.09e-05	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—APOA1—coronary artery disease	1.63e-06	1.08e-05	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—GPX1—coronary artery disease	1.63e-06	1.08e-05	CbGpPWpGaD
Dapagliflozin—UGT2B7—Metabolism—AKT1—coronary artery disease	1.62e-06	1.07e-05	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—APOA1—coronary artery disease	1.62e-06	1.07e-05	CbGpPWpGaD
Dapagliflozin—UGT1A9—Metabolism—PIK3CA—coronary artery disease	1.61e-06	1.07e-05	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—GOT1—coronary artery disease	1.59e-06	1.05e-05	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—GGT1—coronary artery disease	1.59e-06	1.05e-05	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—CD36—coronary artery disease	1.58e-06	1.05e-05	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—PPP2CA—coronary artery disease	1.56e-06	1.04e-05	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	1.55e-06	1.03e-05	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—PPARG—coronary artery disease	1.52e-06	1.01e-05	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—POMC—coronary artery disease	1.5e-06	9.99e-06	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism—PTGS2—coronary artery disease	1.5e-06	9.98e-06	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—MTHFR—coronary artery disease	1.5e-06	9.97e-06	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—PPARG—coronary artery disease	1.44e-06	9.55e-06	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—GSTP1—coronary artery disease	1.43e-06	9.48e-06	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—AGT—coronary artery disease	1.43e-06	9.48e-06	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—PPARG—coronary artery disease	1.42e-06	9.46e-06	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—POMC—coronary artery disease	1.42e-06	9.41e-06	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—PPARGC1A—coronary artery disease	1.41e-06	9.39e-06	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—HMOX1—coronary artery disease	1.41e-06	9.35e-06	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—POMC—coronary artery disease	1.4e-06	9.33e-06	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—APOE—coronary artery disease	1.4e-06	9.28e-06	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—CAT—coronary artery disease	1.39e-06	9.22e-06	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—APOA1—coronary artery disease	1.38e-06	9.18e-06	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—ALB—coronary artery disease	1.37e-06	9.11e-06	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—APOB—coronary artery disease	1.35e-06	8.95e-06	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	1.32e-06	8.79e-06	CbGpPWpGaD
Dapagliflozin—UGT1A9—Metabolism—AKT1—coronary artery disease	1.31e-06	8.73e-06	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—NOS3—coronary artery disease	1.31e-06	8.71e-06	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—GSTM1—coronary artery disease	1.31e-06	8.71e-06	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—ALB—coronary artery disease	1.29e-06	8.58e-06	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—LPL—coronary artery disease	1.29e-06	8.55e-06	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—ALB—coronary artery disease	1.28e-06	8.51e-06	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—GPX1—coronary artery disease	1.25e-06	8.34e-06	CbGpPWpGaD
Dapagliflozin—CYP2A6—Metabolism—PIK3CA—coronary artery disease	1.24e-06	8.24e-06	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—NOS3—coronary artery disease	1.23e-06	8.21e-06	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—NOS3—coronary artery disease	1.22e-06	8.14e-06	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—CD36—coronary artery disease	1.22e-06	8.12e-06	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—PPARG—coronary artery disease	1.22e-06	8.09e-06	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—PPP2CA—coronary artery disease	1.21e-06	8.02e-06	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—POMC—coronary artery disease	1.2e-06	7.98e-06	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—PTGS2—coronary artery disease	1.2e-06	7.97e-06	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—MTHFR—coronary artery disease	1.16e-06	7.7e-06	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—PTGS2—coronary artery disease	1.13e-06	7.51e-06	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—PTGS2—coronary artery disease	1.12e-06	7.44e-06	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—AGT—coronary artery disease	1.1e-06	7.31e-06	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—ALB—coronary artery disease	1.09e-06	7.27e-06	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—APOE—coronary artery disease	1.08e-06	7.17e-06	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—APOA1—coronary artery disease	1.07e-06	7.08e-06	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—NOS3—coronary artery disease	1.05e-06	6.96e-06	CbGpPWpGaD
Dapagliflozin—CYP2A6—Metabolism—AKT1—coronary artery disease	1.01e-06	6.73e-06	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—PTGS2—coronary artery disease	9.57e-07	6.36e-06	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—PPARG—coronary artery disease	9.39e-07	6.24e-06	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—POMC—coronary artery disease	9.26e-07	6.16e-06	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism—PIK3CA—coronary artery disease	9.23e-07	6.14e-06	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—ALB—coronary artery disease	8.44e-07	5.61e-06	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—NOS3—coronary artery disease	8.07e-07	5.37e-06	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism—AKT1—coronary artery disease	7.54e-07	5.01e-06	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—PTGS2—coronary artery disease	7.38e-07	4.91e-06	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—PIK3CA—coronary artery disease	7.37e-07	4.9e-06	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—PIK3CA—coronary artery disease	6.95e-07	4.62e-06	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—PIK3CA—coronary artery disease	6.89e-07	4.58e-06	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—AKT1—coronary artery disease	6.02e-07	4e-06	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—PIK3CA—coronary artery disease	5.89e-07	3.91e-06	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—AKT1—coronary artery disease	5.68e-07	3.77e-06	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—AKT1—coronary artery disease	5.63e-07	3.74e-06	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—AKT1—coronary artery disease	4.81e-07	3.2e-06	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—PIK3CA—coronary artery disease	4.54e-07	3.02e-06	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—AKT1—coronary artery disease	3.71e-07	2.47e-06	CbGpPWpGaD
